Woven Orthopedic Technologies
Woven Orthopedic Technologies is dedicated to improving orthopedic and spine surgery treatments by developing innovative, accessible fixation solutions. Their mission is to make treatments better, easier, more efficient, less expensive, and more widely accessible worldwide. Their flagship product, the Ogmend® Implant Enhancement System, is a patented, clinically proven solution designed to secure stable screw fixation quickly and easily in complex scenarios, with CE Mark and FDA clearance.
Industries
Nr. of Employees
small (1-50)
Woven Orthopedic Technologies
750 E. Main Street, Suite 620, Stamford, CT 06902 USA
Patents
Products
Implant enhancement sleeve for screw fixation (spine and long-bone)
A sterile-packed, off-the-shelf implantable polymer sleeve intended to augment screw purchase where screws have lost fixation due to loosening, back-out, or breakage; designed to increase surface contact, distribute focal stresses, and support bone ingrowth.
Implant enhancement sleeve for screw fixation (spine and long-bone)
A sterile-packed, off-the-shelf implantable polymer sleeve intended to augment screw purchase where screws have lost fixation due to loosening, back-out, or breakage; designed to increase surface contact, distribute focal stresses, and support bone ingrowth.
Services
On-site or remote training and demo sessions supporting clinical adoption of implantable sleeve deployment and surgical technique.
Provision of electronic and hard-copy Instructions for Use and related regulatory documentation in multiple languages for cleared markets.
Partner portal access, partnership request processing, and priority allocation for initial regional product releases.
On-site or remote training and demo sessions supporting clinical adoption of implantable sleeve deployment and surgical technique.
Provision of electronic and hard-copy Instructions for Use and related regulatory documentation in multiple languages for cleared markets.
Partner portal access, partnership request processing, and priority allocation for initial regional product releases.
Expertise Areas
- Orthopedic implant design and development
- Biomaterials and biopolymer manufacturing
- Preclinical in vivo testing
- Clinical evidence generation and publication
Key Technologies
- Implantable polymer sleeves for fixation augmentation
- Porous surface engineering for bone ingrowth
- Finite-element analysis (FEA) for stress distribution
- Preclinical animal fracture and fusion models
News & Updates
In February 2024, Ogmend® received its second FDA clearance for spine applications, allowing the release of the Large size into the US market.
In January 2024, the CEO of Woven was recognized as a top emerging leader in healthcare by Becker's Hospital Review.
In November 2023, Ogmend® was awarded the Spine Technology of the Year by Orthopedics This Week.
In March 2023, Ogmend® received FDA clearance for use in spine surgery in the US.
Various news articles highlight Woven's recent achievements, FDA clearances, awards, and industry recognition.
FDA clearance for the Large size of Ogmend® in February 2024.
In February 2024, Ogmend® received its second FDA clearance for spine applications, allowing the release of the Large size into the US market.
In January 2024, the CEO of Woven was recognized as a top emerging leader in healthcare by Becker's Hospital Review.
In November 2023, Ogmend® was awarded the Spine Technology of the Year by Orthopedics This Week.
In March 2023, Ogmend® received FDA clearance for use in spine surgery in the US.
Various news articles highlight Woven's recent achievements, FDA clearances, awards, and industry recognition.
FDA clearance for the Large size of Ogmend® in February 2024.